Javitt Jonathan C 5
5 · NRX Pharmaceuticals, Inc. · Filed Feb 14, 2023
Insider Transaction Report
Form 5
Javitt Jonathan C
DirectorChairman and Chief Scientist10% Owner
Transactions
- Gift
Common Stock, par value $0.001 per share
2022-12-14−300,000→ 14,468,329 total(indirect: By Trust)
Footnotes (3)
- [F1]Donation of 300,000 shares from the Jonathan Javitt Living Trust to the Jonathan Javitt Donor Advised Fund.
- [F2]Charitable Transfer
- [F3]Consists of (i) 12,599,997 shares of common stock held by the Jonathan Javitt Living Trust, (ii) 1,422,000 shares of common stock held by The Javitt 2012 Irrevocable Dynasty Trust, (iii) 146,332 shares of common stock held by Jonathan Javitt individually and (iv) 300,000 held by the Jonathan Javitt Donor Advised Fund. Jonathan Javitt is the trustee of the Jonathan Javitt Living Trust, the Grantor of The Javitt 2012 Irrevocable Dynasty Trust and the donor and primary advisor of the Jonathan Javitt Donor Advised Fund.